Net Deals Web Search

  1. Ads

    related to: alcon pharmaceuticals fort worth jobs

Search results

  1. ALC - Alcon Inc.

    Yahoo Finance

    89.64+0.51 (+0.57%)

    at Mon, Jun 3, 2024, 4:00PM EDT - U.S. markets open in 4 hours 8 minutes

    Nasdaq Real Time Price

    • Ask Price 89.62
    • Bid Price 0.00
    • P/E 42.48
    • 52 Wk. High 91.08
    • 52 Wk. Low 69.44
    • Mkt. Cap 44.21B
  2. Results From The WOW.Com Content Network
  3. Alcon Laboratories is considering a major $100M ... - AOL

    www.aol.com/alcon-laboratories-considering-major...

    Alcon, which started in Fort Worth and has grown to become the world’s largest eye care device company, is looking to invest an estimated $100 million to build a 250,000-square-foot ...

  4. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.

  5. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

  6. List of largest biomedical companies by revenue - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...

  7. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  8. Alexion Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Alexion_Pharmaceuticals

    Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases . Its products include eculizumab (Soliris) and ravulizumab (Ultomiris), both used to treat the rare disorders of atypical hemolytic uremic ...